Stem Cells and Bone Tissue Engineering
Life · 21.02.2024 · 14 (3) · 287
DOI: 10.3390/life14030287 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life, online erschienen am 21.02.2024. Verfasst von Xueqin Gao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Linda and Mitch Hart Center for Regenerative and Personalized Medicine, Steadman Philippon Research Institute, Vail, CO 81657, USA. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 206 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mary Sue and Mike Shannon Network.
Abstract (Originalsprache)
Segmental bone defects that are caused by trauma, infection, tumor resection, or osteoporotic fractures present significant surgical treatment challenges. Host bone autograft is considered the gold standard for restoring function but comes with the cost of harvest site comorbidity. Allograft bone is a secondary option but has its own limitations in the incorporation with the host bone as well as its cost. Therefore, developing new bone tissue engineering strategies to treat bone defects is critically needed. In the past three decades, the use of stem cells that are delivered with different scaffolds or growth factors for bone tissue engineering has made tremendous progress. Many varieties of stem cells have been isolated from different tissues for use in bone tissue engineering. This review summarizes the progress in using different postnatal stem cells, including bone marrow mesenchymal stem cells, muscle-derived stem cells, adipose-derived stem cells, dental pulp stem cells/periodontal ligament stem cells, periosteum stem cells, umbilical cord-derived stem cells, peripheral blood stem cells, urine-derived stem cells, stem cells from apical papilla, and induced pluripotent stem cells, for bone tissue engineering and repair. This review also summarizes the progress using exosomes or extracellular vesicles that are delivered with various scaffolds for bone repair. The advantages and disadvantages of each type of stem cell are also discussed and explained in detail. It is hoped that in the future, these preclinical results will translate into new regenerative therapies for bone defect repair.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Linda and Mitch Hart Center for Regenerative and Personalized Medicine, Steadman Philippon Research Institute, Vail, CO 81657, USA.
- The Steadman Clinic, Aspen, CO 81611, USA.
- Glassell School of Art, The Museum of Fine Arts, Houston, TX 77006, USA.
ORCID-Profile: Xueqin Gao, Jonathan E Layne
Förderung
- Mary Sue and Mike Shannon Network
Zitieren
APA
Gao, X., Ruzbarsky, J. J., Layne, J. E., Xiao, X., & Huard, J. (2024). Stem Cells and Bone Tissue Engineering. Life, 14(3), 287. https://doi.org/10.3390/life14030287
Vancouver
Gao X, Ruzbarsky JJ, Layne JE, Xiao X, Huard J. Stem Cells and Bone Tissue Engineering. Life. 2024;14(3):287. doi:10.3390/life14030287
BibTeX
@article{Gao2024,
author = {Gao, Xueqin and Ruzbarsky, Joseph J and Layne, Jonathan E and Xiao, Xiang and Huard, Johnny},
title = {Stem Cells and Bone Tissue Engineering},
journal = {Life},
year = {2024},
volume = {14},
number = {3},
pages = {287},
doi = {10.3390/life14030287}
}
EUVIMED